SAN DIEGO, California — A review of prescription patterns reveals calcitonin gene-related peptide (CGRP) and gepant medications for migraine reveals significant gender and racial disparities that may affect access to care and health equity. “The study serves as an early steppingstone in identifying opportunities for further research and intervention to expand access to migraine therapeutics,” …
Read More
